| Scenario Name                | Date    | Euro area real GDP growth | Euro area inflation | Euro area bilateral dollar exchange rate (USD/euro) | Developing Asia real GDP growth | Developing Asia inflation | Developing Asia bilateral dollar exchange rate (F/USD, index) | Japan real GDP growth | Japan inflation | Japan bilateral dollar exchange rate (yen/USD) | U.K. real GDP growth | U.K. inflation | U.K. bilateral dollar exchange rate (USD/pound) |
|------------------------------|---------|---------------------------|---------------------|-----------------------------------------------------|---------------------------------|---------------------------|---------------------------------------------------------------|-----------------------|-----------------|------------------------------------------------|----------------------|----------------|-------------------------------------------------|
| Supervisory Severely Adverse | 2024 Q1 | -4.7                      | 1.5                 | 1.092                                               | -2.4                            | -0.1                      | 105.8                                                         | -9.2                  | 0.9             | 139.1                                          | -3.8                 | 2.0            | 1.257                                           |
| Supervisory Severely Adverse | 2024 Q2 | -4.1                      | 0.7                 | 1.077                                               | -1.6                            | -1.8                      | 107.3                                                         | -6.8                  | -0.1            | 138.6                                          | -4.2                 | 1.2            | 1.241                                           |
| Supervisory Severely Adverse | 2024 Q3 | -3.2                      | 0.8                 | 1.042                                               | -0.2                            | -1.4                      | 110.9                                                         | -5.0                  | -0.8            | 138.4                                          | -3.4                 | 1.1            | 1.200                                           |
| Supervisory Severely Adverse | 2024 Q4 | -3.0                      | 0.3                 | 1.014                                               | 0.1                             | -2.1                      | 113.9                                                         | -4.6                  | -1.6            | 138.1                                          | -3.2                 | 0.7            | 1.169                                           |
| Supervisory Severely Adverse | 2025 Q1 | -2.8                      | -0.3                | 1.008                                               | 1.3                             | -2.7                      | 114.6                                                         | -4.1                  | -1.9            | 137.8                                          | -3.0                 | 0.2            | 1.161                                           |
| Supervisory Severely Adverse | 2025 Q2 | -2.6                      | -0.7                | 1.001                                               | 1.9                             | -2.8                      | 115.4                                                         | -3.7                  | -2.1            | 137.7                                          | -2.8                 | -0.2           | 1.153                                           |
| Supervisory Severely Adverse | 2025 Q3 | 1.0                       | -0.5                | 1.004                                               | 4.3                             | -1.9                      | 115.0                                                         | 1.0                   | -1.5            | 137.8                                          | 1.0                  | 0.0            | 1.157                                           |
| Supervisory Severely Adverse | 2025 Q4 | 3.6                       | -0.4                | 1.008                                               | 5.6                             | -1.3                      | 114.6                                                         | 4.5                   | -0.9            | 137.9                                          | 3.5                  | 0.2            | 1.161                                           |
| Supervisory Severely Adverse | 2026 Q1 | 4.5                       | -0.1                | 1.021                                               | 6.0                             | -0.7                      | 113.1                                                         | 5.5                   | -0.1            | 138.1                                          | 4.4                  | 0.5            | 1.176                                           |
| Supervisory Severely Adverse | 2026 Q2 | 5.4                       | 0.1                 | 1.049                                               | 6.3                             | -0.4                      | 110.1                                                         | 6.5                   | 0.7             | 138.2                                          | 5.3                  | 0.7            | 1.208                                           |
| Supervisory Severely Adverse | 2026 Q3 | 6.3                       | 0.5                 | 1.063                                               | 6.7                             | 0.6                       | 108.7                                                         | 7.0                   | 1.3             | 138.4                                          | 6.2                  | 1.2            | 1.224                                           |
| Supervisory Severely Adverse | 2026 Q4 | 7.2                       | 1.0                 | 1.077                                               | 6.9                             | 1.4                       | 107.3                                                         | 7.5                   | 1.8             | 138.5                                          | 7.0                  | 1.7            | 1.241                                           |
| Supervisory Severely Adverse | 2027 Q1 | 8.1                       | 1.6                 | 1.092                                               | 6.8                             | 2.3                       | 105.8                                                         | 8.5                   | 2.4             | 138.7                                          | 7.9                  | 2.2            | 1.257                                           |